CervoMed
CRVO
CervoMed (CRVO) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.84
- EPS estimate
- −$0.66
- EPS surprise
- −27.83%
- Revenue surprise
- −73.44%
- Revenue
- $322,569.00
- Revenue estimate
- $1.2M
- Reported
- Nov 7, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 7, 2025 | −$0.66 | −$0.84 | −27.83% | $322,569.00 | SEC |
| Q2 2025 | Aug 8, 2025 | −$0.61 | −$0.70 | −13.88% | $1.8M | SEC |
| Q1 2025 | May 12, 2025 | −$0.63 | −$0.56 | +10.87% | $1.9M | SEC |
| Q4 2024 | Mar 17, 2025 | −$0.63 | −$0.77 | −21.39% | $2.2M | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.41 | −$0.55 | −33.50% | $1.9M | SEC |
| Q2 2024 | Aug 9, 2024 | −$0.31 | −$0.27 | +11.76% | $3.3M | SEC |
| Q1 2024 | May 14, 2024 | −$0.39 | −$0.41 | −5.13% | $2.3M | SEC |
| Q4 2023 | Mar 29, 2024 | −$0.62 | −$0.12 | +81.45% | $2.5M | SEC |
| Q3 2023 | Nov 13, 2023 | −$0.95 | −$0.70 | +26.32% | $1.5M | SEC |
| Q2 2023 | Aug 8, 2023 | −$2.90 | −$3.04 | −5.01% | $0.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$3.09 | −$2.06 | +33.50% | $0.00 | — |
| Q2 2022 | Aug 12, 2022 | −$3.06 | −$3.09 | −0.98% | $0.00 | — |
| Q1 2022 | May 12, 2022 | −$2.63 | −$3.33 | −26.86% | $0.00 | — |
| Q3 2021 | Nov 10, 2021 | −$3.00 | −$9.00 | −200.00% | $0.00 | — |
| Q2 2021 | Aug 11, 2021 | −$3.38 | −$3.00 | +11.11% | $0.00 | — |
| Q4 2020 | Mar 17, 2021 | −$4.13 | −$4.50 | −9.09% | $0.00 | — |
| Q3 2020 | Nov 12, 2020 | −$4.13 | −$5.25 | −27.27% | $0.00 | — |
| Q1 2020 | May 11, 2020 | −$6.38 | −$5.25 | +17.65% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did CervoMed (CRVO) last report earnings?
CervoMed last reported on Nov 7, 2025, covering fiscal Q3 2025.
Did CRVO beat earnings estimates?
No. CervoMed reported EPS of −$0.84 for Q3 2025 against a −$0.66 estimate — a 27.83% miss.
How much revenue did CRVO report last quarter?
CervoMed reported $322,569.00 in revenue for Q3 2025, against a consensus estimate of $1.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.